CD150-mediated Akt signalling pathway in normal and malignant B cells
Aim of this article is to study upstream and downstream events in CD150-mediated Akt signaling pathway in normal human B cells, EBV-transformed lymphoblastoid (LCL) and malignant Hodgkin’s lymphoma (HL) B cell lines.
Saved in:
Date: | 2011 |
---|---|
Main Authors: | Yurchenko, M., Shlapatska, L.M., Romanets, O.L., Ganshevskiy, D., Kashuba, E., Zamoshnikova, A., Ushenin, Yu.V., Snopok, B.A., Sidorenko, S.P. |
Format: | Article |
Language: | English |
Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2011
|
Series: | Experimental Oncology |
Subjects: | |
Online Access: | http://dspace.nbuv.gov.ua/handle/123456789/32312 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
Cite this: | CD150-mediated Akt signalling pathway in normal and malignant B cells / M. Yurchenko, L.M. Shlapatska, O.L. Romanets, D. Ganshevskiy, E. Kashuba, A. Zamoshnikova, Yu.V. Ushenin, B.A. Snopok, S.P. Sidorenko // Experimental Oncology. — 2011. — Т. 33, № 1. — С. 9-18. — Біліогр.: 53 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
-
Differential expression of CD150/SLAMF1 in normal and malignant b cells on the different stages of maturation
by: Gordiienko, I.M., et al.
Published: (2016) -
Intrinsic defect in B-lymphoblastoid cell lines from patients with X-linked lymphoproliferative disease type 1. II. Receptor-mediated Akt/PKB and ERK1/2 activation and transcription factors expression profile
by: Shlapatska, L.M., et al.
Published: (2014) -
Immunohistochemical studies of protein kinase D (PKD) 2 expression in malignant human lymph
by: Shlapatska, L.M., et al.
Published: (2006) -
CD150 and CD180 are involved in regulation of transcription factors expression in chronic lymphocytic leukemia cells
by: Gordiienko, I.M., et al.
Published: (2017) -
The TGF-beta — SMAD pathway is inactivated in cronic lymphocytic leukemia cells
by: Matveeva, A., et al.
Published: (2017)